Valuence Merger Corp I (VMCA) - Total Liabilities
Based on the latest financial reports, Valuence Merger Corp I (VMCA) has total liabilities worth $12.90 Million USD as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check VMCA cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Valuence Merger Corp I - Total Liabilities Trend (2021–2024)
This chart illustrates how Valuence Merger Corp I's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see VMCA current and non-current assets.
Valuence Merger Corp I Competitors by Total Liabilities
The table below lists competitors of Valuence Merger Corp I ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
I Jang Industrial Co Ltd
TWO:8342
|
Taiwan | NT$618.41 Million |
|
LOT VACUUM Co. Ltd
KQ:083310
|
Korea | ₩86.94 Billion |
|
Pyxis Oncology Inc
NASDAQ:PYXS
|
USA | $36.83 Million |
|
Aluma Infrastructure Fund 2020 Ltd
TA:ALUMA
|
Israel | ILA354.51 Million |
|
Raonsecure Co. Ltd
KQ:042510
|
Korea | ₩20.77 Billion |
|
IBI Lion SOCIMI S.A.
MC:YIBI
|
Spain | €54.88 Million |
|
Cartica Acquisition Corp
NASDAQ:CITE
|
USA | $8.99 Million |
|
BioPorto
CO:BIOPOR
|
Denmark | Dkr30.17 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down Valuence Merger Corp I's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See VMCA net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.56 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Valuence Merger Corp I's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Valuence Merger Corp I (2021–2024)
The table below shows the annual total liabilities of Valuence Merger Corp I from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $12.44 Million | -2.75% |
| 2023-12-31 | $12.80 Million | +23.48% |
| 2022-12-31 | $10.36 Million | +1570.45% |
| 2021-12-31 | $620.39K | -- |
About Valuence Merger Corp I
Valuence Merger Corp. I does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in developing breakthrough technology in life sciences and/or advancing a platform for sustainable technology in Asia. The company was incorporated in 2021 and is base… Read more